|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61J 3/00 | |
| A61B 5/00 |
| (11) | Number of the document | 2083680 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07868581.5 |
| Date of filing the European patent application | 2007-10-25 | |
| (97) | Date of publication of the European application | 2009-08-05 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/082563 |
| Date | 2007-10-25 |
| (87) | Number | WO 2008/052136 |
| Date | 2008-05-02 |
| (30) | Number | Date | Country code |
| 862925 P | 2006-10-25 | US |
| (72) |
HAFEZI, Hooman, US
ROBERTSON, Timothy, US
COLLIOU, Oliver, US
|
| (73) |
Proteus Digital Health, Inc.,
2600 Bridge Parkway, Suite 101, Redwood City, CA 94065,
US
|
| (54) | CONTROLLED ACTIVATION INGESTIBLE IDENTIFIER |
| CONTROLLED ACTIVATION INGESTIBLE IDENTIFIER |